Determinants of peak bone mass

Annales d'Endocrinologie

Volumn 67, Issue 2, 2006, Pages 114-115

  Rizzoli, R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

BONE DENSITY; BONE MASS; DIETARY INTAKE; FRACTURE; GENETIC VARIABILITY; HUMAN; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; SHORT SURVEY; VITAMIN SUPPLEMENTATION;

EID: 33646432777     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)72564-1     Document Type: Article

References (19)

1. Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 1999 ; 104 : 795-804.
2. Bonjour JP, Carrie AL, Ferrari S et al. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 1997 ; 99 : 1287-94.
3. Chevalley T, Bonjour JP, Ferrari S, Hans D, Rizzoli R. Skeletal site selectivity in the effects of calcium supplementation on areal bone mineral density gain: a randomized, double-blind, placebo-controlled trial in prepubertal boys. J Clin Endocrinol Metab 2005 ; 90 : 3342-9.
4. Chevalley T, Rizzoli R, Hans D, Ferrari S, Bonjour JP. Interaction between calcium intake and menarcheal age on bone mass gain: an eight-year follow-up study from prepuberty to postmenarche. J Clin Endocrinol Metab 2005 ; 90 : 44-51.
5. Eastell R. Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 2005 ; 185 : 223-34.
6. Ferrari S, Rizzoli R, Slosman D, Bonjour JP. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998 ; 83 : 358-61.
7. Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res 1998 ; 13 : 363-70.
8. Heaney RP, Abrams S, Dawson-Hughes B et al. Peak bone mass. Osteoporos Int 2000 ; 11 : 985-1009.
9. Johnell O, Scheele WH, Lu Y, Reginster JY, Need AG, Seeman E. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002 ; 87 : 985-92.
10. Murphy NM, Carroll P. The effect of physical activity and its interaction with nutrition on bone health. Proc Nutr Soc 2003 ; 62 : 829-38.
11. Parfitt AM. Misconceptions (1): epiphyseal fusion causes cessation of growth. Bone 2002 ; 30 : 337-9.
12. Parfitt AM. Misconceptions (2): turnover is always higher in cancellous than in cortical bone. Bone 2002 ; 30 : 807-9.
13. Rauch F, Klein K, Allolio B, Schonau E. Age at menarche and cortical bone geometry in premenopausal women. Bone 1999 ; 25 : 69-73.
14. Rauch F, Travers R, Norman ME, Taylor A, Parfitt AM, Glorieux FH. The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone 2002 ; 31 : 85-9.
15. Rizzoli R, Bonjour JP. Determinants of peak bone mass and mechanisms of bone loss. Osteoporos Int 1999 ; 9 (Suppl. 2) : S17-S23.
16. Rizzoli R, Bonjour JP. Dietary protein and bone health. J Bone Miner Res 2004 ; 19 : 527-31.
17. Rosen CJ. Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies. Best Pract Res Clin Endocrinol Metab 2004 ; 18 : 423-35.
18. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 2001 ; 86 : 4576-84.
19. Theintz G, Buchs B, Rizzoli R et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992 ; 75 : 1060-5.